NASDAQ · TLSI
TriSalus Life Sciences, Inc.
$3.86-$0.07 (-1.78%)
TriSalus Life Sciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.45% below the high.
Loading market information…
NASDAQ · NRAC · USD
Stock price, earnings
Quote as of Feb 14, 2024, 08:09 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Noble Rock Acquisition Corporation’s quoted price sits in the lower half of its reported 52-week range, 8.18% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Noble Rock Acquisition Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Noble Rock Acquisition Corporation currently maintains no significant active business operations. Its strategic objective is to pursue and execute a business combination, such as a merger, capital stock exchange, asset acquisition, stock purchase, or reorganization, involving one or more enterprises within the software and technology-enabled services industries. The firm commenced operations in 2020 and has its principal executive offices located in Wilmington, Delaware.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$3.86-$0.07 (-1.78%)
TriSalus Life Sciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.45% below the high.
$12.60-$0.24 (-1.87%)
DP Cap Acquisition Corp I’s quoted price sits in the lower half of its reported 52-week range, 19.59% below the high.
$7.87+$0.75 (+10.53%)
Twin Ridge Capital Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 48.9% below the high.
$10.50-$0.07 (-0.66%)
Williams Rowland Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 1.41% below the high.
$10.25+$0.01 (+0.05%)
Belong Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 4.12% below the high.
$14.95-$0.05 (-0.33%)
Integrated Rail and Resources Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 12.11% below the high.
$10.95-$0.02 (-0.18%)
Quadro Acquisition One Corp.’s quoted price sits in the lower half of its reported 52-week range, 6.73% below the high.
$10.76$0.00 (0.0%)
Portage Fintech Acquisition Corporation’s quoted price sits in the lower half of its reported 52-week range, 16.98% below the high.
